Raisecom Technology (603803.SH) is expected to incur a net loss of approximately 124 million yuan in the fiscal year 2024.
Ruikangda (603803.SH) released an announcement, the company expects to achieve a net profit attributable to shareholders of the listed company in the annual report of 2024.
Raisecom Technology (603803.SH) announced that the company is expected to incur a net profit loss of approximately 124 million yuan attributable to shareholders of the listed company in the fiscal year 2024. Compared to the same period last year, the expected reduction in the loss amount is about 78 million yuan.
During the reporting period, the company was affected by a combination of internal and external factors such as the slowdown in global economic recovery, insufficient momentum in downstream investment and consumer demand, intensifying industry competition, continuous growth in overseas income but with a small proportion, and the lack of scale contribution from new product research and development iteration and market promotion. Although the comprehensive gross profit margin remained stable during the reporting period, the operating income decreased by 15% year-on-year, leading to a decrease in gross profit amount.
Related Articles

Before next week's financial report, Bank of America "cautiously bullish" on Ford (F.US) and General Motors (GM.US): Strong fundamentals are difficult to resist short-term risks.

On October 17, Jiangsu Hengrui Pharmaceuticals (01276) spent 25.5768 million yuan to repurchase 392,600 A-shares.

Did the "meat sign" that was in hand fly away? (02637) Is it a delayed listing or a forced suspension?
Before next week's financial report, Bank of America "cautiously bullish" on Ford (F.US) and General Motors (GM.US): Strong fundamentals are difficult to resist short-term risks.

On October 17, Jiangsu Hengrui Pharmaceuticals (01276) spent 25.5768 million yuan to repurchase 392,600 A-shares.

Did the "meat sign" that was in hand fly away? (02637) Is it a delayed listing or a forced suspension?

RECOMMEND